BioMerieux SA (XPAR:BIM)
€ 98.85 -0.2 (-0.2%) Market Cap: 11.66 Bil Enterprise Value: 11.94 Bil PE Ratio: 28.34 PB Ratio: 3.00 GF Score: 98/100

Q3 2022 Biomerieux SA Corporate Sales Call Transcript

Oct 26, 2022 / 01:00PM GMT
Release Date Price: €91.52 (-0.85%)
Operator

Good day, and welcome to the bioMérieux Q3 sales release conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Admant. Please go ahead, sir.

Franck Admant;rieux S.A.;Director of IR
bioMÃ

©-

Thank you. Good afternoon, and thank you for joining us to review bioMérieux performance of its third quarter of 2022. As usual, I am online with Alexandre Merieux, Chairman and CEO; as well as Guillaume Bouhours, CFO. Before handing the call over to Alex Merieux for preliminary remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer stating that forward-looking statements are based entirely or partially on assessments of regimens that may change or be modified due to uncertainties and risks related to the company's environment, notably those described in the 2021 registration documents, including but not limited to economic conditions, financial exposures, currency exchange fluctuations, change in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot